Aldeyra Therapeutics, Inc. (ALDX) DCF Valuation

Aldeyra Therapeutics, Inc. (ALDX) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

Aldeyra Therapeutics, Inc. (ALDX) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Engineered for accuracy, our (ALDX) DCF Calculator empowers you to evaluate Aldeyra Therapeutics, Inc. valuation using up-to-date financial information and offers complete flexibility to modify all essential parameters for enhanced projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -61.4 -36.1 -55.8 -60.1 -35.2 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .1 .1 .3 .3 .3 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -61.5 -36.1 -56.0 -60.3 -35.5 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 73.4 77.9 229.8 174.3 142.8 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 125.0 3.2 .0
Account Receivables, % 100 100 100 100 100
Inventories -28.0 -20.2 -125.0 -3.2 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .8 .4 1.0 .1 1.3 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -60.2 -35.7 -57.5 -59.7 -35.5 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -31.3 -43.8 -76.8 -60.3 -34.0 -1.3 .0 .0 .0 .0
WACC, % 11.3 11.3 11.31 11.31 11.31 11.31 11.31 11.31 11.31 11.31
PV UFCF
SUM PV UFCF -1.2
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -1
Net Debt -127
Equity Value 126
Diluted Shares Outstanding, MM 59
Equity Value Per Share 2.14

What You Will Get

  • Editable Forecast Inputs: Effortlessly modify key assumptions (growth %, margins, WACC) to explore various scenarios.
  • Real-World Data: Aldeyra Therapeutics, Inc. (ALDX) financial data pre-filled to enhance your analysis.
  • Automatic DCF Outputs: The template automatically calculates Net Present Value (NPV) and intrinsic value for your convenience.
  • Customizable and Professional: A refined Excel model that adjusts to meet your valuation requirements.
  • Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and optimizing your time.

Key Features

  • Comprehensive Data: Aldeyra Therapeutics’ historical financial statements and pre-filled projections.
  • Customizable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins to fit your analysis.
  • Real-Time Calculations: Observe Aldeyra Therapeutics’ intrinsic value update instantly.
  • Intuitive Visuals: Dashboard graphs showcase valuation results and essential metrics.
  • Designed for Precision: A reliable tool for analysts, investors, and finance professionals.

How It Works

  • Step 1: Download the prebuilt Excel template featuring Aldeyra Therapeutics, Inc. (ALDX) data.
  • Step 2: Review the pre-filled sheets to familiarize yourself with the essential metrics.
  • Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly see recalculated results, including Aldeyra Therapeutics, Inc. (ALDX)'s intrinsic value.
  • Step 5: Make well-informed investment decisions or create reports based on the outputs.

Why Choose This Calculator for Aldeyra Therapeutics, Inc. (ALDX)?

  • Accurate Data: Utilize real Aldeyra financials for dependable valuation outcomes.
  • Customizable: Tailor essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
  • Time-Saving: Pre-configured calculations save you from having to start from the ground up.
  • Professional-Grade Tool: Crafted for investors, analysts, and consultants in the biotech sector.
  • User-Friendly: An intuitive interface with clear, step-by-step guidance makes it accessible for everyone.

Who Should Use This Product?

  • Investors: Evaluate Aldeyra Therapeutics’ valuation before making investment decisions.
  • CFOs and Financial Analysts: Optimize valuation methodologies and assess financial forecasts.
  • Startup Founders: Understand how biotech companies like Aldeyra Therapeutics are appraised.
  • Consultants: Provide detailed valuation analyses and reports for clients in the biotech sector.
  • Students and Educators: Utilize real-time data to learn and teach valuation practices in biotechnology.

What the Aldeyra Therapeutics, Inc. (ALDX) Template Contains

  • Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for Aldeyra Therapeutics.
  • Real-World Data: Aldeyra’s historical and projected financials preloaded for in-depth analysis.
  • Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to explore various scenarios.
  • Financial Statements: Complete annual and quarterly breakdowns for enhanced insights.
  • Key Ratios: Integrated analysis for profitability, efficiency, and leverage specific to Aldeyra.
  • Dashboard with Visual Outputs: Charts and tables providing clear, actionable results for stakeholders.

No products were found matching.